Makers Laboratories enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast close	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023


112	—	—	—	—
0.0	0.0	0.0	0.0	0.0
2.7	2.7	0.3	13.6	9.2
114	—	—	—	—
2.7	2.7	0.3	13.6	9.2
₹193.72	—	—	—	—

57.1	57.1	56.4	65.0	67.5
4.7%	4.7%	0.5%	20.9%	13.7%
0.02×	—	—	—	—

2.27×	—	—	—	—
156.71×	—	—	—	—
−55.22×	—	—	—	—
−56.65×	—	—	—	—
50.3	50.3	42.9	49.1	42.5
0.7	0.7	−2.2	−3.8	−4.1
−2.1	−2.1	−5.1	−6.5	−6.5
−2.0	−2.0	−1.6	−3.1	−1.4
−2.3	−2.3	−4.0	−5.8	−5.9
−2.4	−2.4	−4.2	−5.8	−6.0
0.3	0.3	2.4	2.7	4.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

MAKERSL₹189.18

Makers Laboratories Limited

· Pharma & Health

₹ CrorePeersBPLPHARMA JENBURPH KPL NOVARTIND PARNAXLAB SGRL SHUKRAPHAR SUNLOCMcap ₹112 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current last close
Market Capitalization	—	—	—	—	111.8
- Cash, Equiv & ST Investments	0.0	0.0	0.0	0.0	0.0
+ Total Debt	9.2	13.6	0.3	2.7	2.7
Enterprise Value	—	—	—	—	114.5
Net Debt (memo)	9.2	13.6	0.3	2.7	2.7
EV per Share	—	—	—	—	193.72

Total Capital	67.5	65.0	56.4	57.1	57.1
Total Debt/Total Capital	13.69	20.89	0.53	4.73	4.73
Total Debt/EV	—	—	—	—	0.02

EV/Sales	—	—	—	—	2.27
EV/EBITDA	—	—	—	—	156.71
EV/EBIT	—	—	—	—	-55.22
EV/Operating Cash Flow	—	—	—	—	-56.65
Reference Items — Trailing FY Values
Sales	42.5	49.1	42.9	50.3	50.3
EBITDA	-4.1	-3.8	-2.2	0.7	0.7
EBIT	-6.5	-6.5	-5.1	-2.1	-2.1
Operating Cash Flow	-1.4	-3.1	-1.6	-2.0	-2.0
Free Cash Flow	-5.9	-5.8	-4.0	-2.3	-2.3
FCFF (free cash flow to the firm)	-6.0	-5.8	-4.2	-2.4	-2.4
Capital Expenditure	4.5	2.7	2.4	0.3	0.3

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.